What are the psychological effects of using synthetic cannabinoids? A systematic review

被引:30
作者
Akram, Hina [1 ,2 ]
Mokrysz, Claire [2 ]
Curran, H. Valerie [2 ]
机构
[1] UCL, Dept Clin Educ & Hlth Psychol, 1-19 Torrington Pl, London WC1E 6BT, England
[2] UCL, UCL Clin Psychopharmacol Unit, London WC1E 6BT, England
基金
英国医学研究理事会;
关键词
Synthetic cannabis; psychological; behavioural; affective; cognitive; depression; anxiety; systematic review; CONSUMPTION; PSYCHOSIS; SPICE; PREVALENCE; ADOLESCENT; TOXICITY; PATTERNS; JWH-018;
D O I
10.1177/0269881119826592
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Synthetic cannabinoids are, typically, full agonists at the cannabinoid CB1 receptor, and therefore considerably more potent than natural cannabis and may have correspondingly more serious psychological effects. Despite government sanctions against their production they continue to be available in ever-increasing varieties over the Internet. The psychological consequences of synthetic cannabinoid use are relatively unknown. Aim: The purpose of this study was to synthesise the available research on the psychological consequences of synthetic cannabinoid use. Method: A literature search of three databases was conducted in February 2018, including the following keywords: Spice, synthetic cannabis, cognition, affect, behaviour, psychosis, depression and anxiety. Results: Seventeen studies involving a variety of participants were eligible for inclusion: one controlled administration study, seven cross-sectional studies, five Internet surveys and four qualitative studies. The controlled administration study showed that, compared to placebo, synthetic cannabinoids acutely affected some aspects of cognitive functioning and subjective psychological ratings. Non-controlled, cross-sectional studies generally showed that synthetic cannabinoid users had lower performance on cognitive tasks and showed elevated symptomatology (e.g. paranoia) compared to both natural cannabis and non-cannabis users. Methodological limitations were noted across different study designs. There is limited research on how doses, frequency or type of synthetic cannabinoid influence outcomes. Conclusions: Acute synthetic cannabinoid use can result in a range of psychological outcomes and, when non-intoxicated, synthetic cannabinoid users appear to differ from natural cannabis and non-users on various affective and cognitive domains. As synthetic cannabinoid use is increasing in at-risk populations there is an urgent need for more and better research to inform users, professionals and policymakers.
引用
收藏
页码:271 / 283
页数:13
相关论文
共 56 条
  • [1] Albertson Timothy E, 2016, FP Essent, V441, P11
  • [2] Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients
    Altintas, Merih
    Inanc, Leman
    Oruc, Gamze Akcay
    Arpacioglu, Selim
    Gulec, Huseyin
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1893 - 1900
  • [3] [Anonymous], 2004, Standard quality assessment criteria for evaluating primary research papers from a variety of fields. (HTA Initiative #13), DOI DOI 10.7939/R37M04F16
  • [4] 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
    Auwaerter, Volker
    Dresen, Sebastian
    Weinmann, Wolfgang
    Mueller, Michael
    Puetz, Michael
    Ferreiros, Nerea
    [J]. JOURNAL OF MASS SPECTROMETRY, 2009, 44 (05): : 832 - 837
  • [5] Patterns of synthetic cannabinoid use in Australia
    Barratt, Monica J.
    Cakic, Vince
    Lenton, Simon
    [J]. DRUG AND ALCOHOL REVIEW, 2013, 32 (02) : 141 - 146
  • [6] A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes
    Blevins, Claire E.
    Banes, Kelsey E.
    Stephens, Robert S.
    Walker, Denise D.
    Roffman, Roger A.
    [J]. ADDICTIVE BEHAVIORS, 2016, 63 : 114 - 119
  • [7] Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates
    Bonar, Erin E.
    Ashrafioun, Lisham
    Ilgen, Mark A.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2014, 143 : 268 - 271
  • [8] A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids
    Brewer, Tracy L.
    Collins, Margie
    [J]. JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING, 2014, 19 (02) : 119 - 126
  • [9] Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series
    Celofiga, Andreja
    Koprivsek, Jure
    Klavz, Janez
    [J]. JOURNAL OF DUAL DIAGNOSIS, 2014, 10 (03) : 168 - 173
  • [10] Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana
    Clayton, Heather B.
    Lowry, Richard
    Ashley, Carmen
    Wolkin, Amy
    Grant, Althea M.
    [J]. PEDIATRICS, 2017, 139 (04)